FDA Clears AccelSPINE's Next Generation Minimally Invasive Spine System

Spinal Tech

AccelSPINE has received U.S. Food and Drug Administration clearance on its Picasso II system.

Picasso II is intended to immobilize and stabilize spinal segments as a supplement to fusion during the treatment of acute and chronic instabilities or deformities of the spine. It is an addition to the company's Picasso product line.

 

AccelSPINE is a national medical device company that designs, develops and manufactures spinal implants and instruments.

More Articles on Devices:

Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.